Shanghai ERP Biotechnology: difference between revisions
Diff·revision 18 → 19·06:14, 17 Dec 2025
Difference between revision 18 and revision 19 of Shanghai ERP Biotechnology. 7 lines changed; the page grew by 592 bytes.
| Revision 18 — 07:23, 6 Dec 2025 HypoHildur (talk) rm the comparison with another supplier; there is no common basis for it 9,648 bytes +363 | Revision 19 — 06:14, 17 Dec 2025 CiteBot (talk) bot: sort category members 10,240 bytes +592 | ||
|---|---|---|---|
| 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 72 | 72 | ||
| + | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | |
| + | 74 | ||
| 73 | == Reception == | 75 | == Reception == |
| 74 | The PeptidePedia tally records 812 self-reported submissions to July 2026. Recurring themes are delivery reliability and responsiveness; a small number of submissions also record endotoxin results, which are close to absent from submissions about any other entity covered here.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 76 | The PeptidePedia tally records 812 self-reported submissions to July 2026. Recurring themes are delivery reliability and responsiveness; a small number of submissions also record endotoxin results, which are close to absent from submissions about any other entity covered here.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 84 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 86 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 85 | 87 | ||
| + | 88 | == Further reading == | |
| + | 89 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 90 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 91 | ||
| 86 | == See also == | 92 | == See also == |
| 87 | * [[Certificate of analysis]] | 93 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 91 | * [[Research use only]] | 97 | * [[Research use only]] |
| 92 | * [[Peptide supply chain]] | 98 | * [[Peptide supply chain]] |
| + | 99 | * [[Blind sampling]] | |
| 93 | 100 | ||
| 94 | {{DEFAULTSORT:Shanghai ERP Biotechnology}} | 101 | {{DEFAULTSORT:Shanghai ERP Biotechnology}} |